TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
XLO

Xilio Development Inc

Healthcare · Biotechnology

9.10$ +0.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Xilio Development Inc (XLO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -5.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow XLO
Line item 2019 2020 2021 2022 2023 2024 2025
-18 -36 -81 -76 -69 -18 -5.0
0.2 1.1 1.5 1.8 1.9 1.6 1.5
0.1 1.3 5.0 8.4 7.4 6.4 6.9
-1.6 1.5 5.2 8.6 – – –
0.8 17 -12 2.0 -1.7 32 25
0.7 2.2 1.1 1.9 0.5 0.0 0.5
-0.7 -2.2 -1.1 -1.9 -0.5 0.0 -0.5
– – 262 0.0 0.2 – 2.8
10.0 -0.1 0.0 -0.1 -6.8 -3.4 0.0
60 10 261 -0.1 -6.6 29 88
41 -28 179 -78 -76 11 82
-19 -38 -82 -78 -69 -18 -5.5

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?